The resulting model, HydrAffinity, is an interaction-free, dynamic sparse model that uses pre-trained encoders and MoE for parameter-efficient learning and outperforms all interaction-free methods and matches state-of-the-art interaction-based methods on CASF-2016.
Abstract
Protein-ligand affinity (PLA) prediction is central to AI-driven drug discovery, but precise interaction-based methods require costly conformation preparation and data encoding, limiting their throughput. To reconcile accuracy with efficiency, we first investigate whether pre-trained molecular representation models can replace complex encoders. A unified and diverse assessment of sequence-, graph-, and image-based representations reveals both strong overall performance and family-wise variability, delivering the first practical guidance for encoder selection in PLA tasks. Next, to achieve high computational efficiency without sacrificing expressiveness, we adopt the mixture-of-experts (MoE) strategy from large language models. Systematic ablation studies uncover key design principles for deploying MoE in molecular prediction. The resulting model, HydrAffinity, is an interaction-free, dynamic sparse model that uses pre-trained encoders and MoE for parameter-efficient learning. It outperforms all interaction-free methods and matches state-of-the-art interaction-based methods on CASF-2016. Routing analysis confirms that MoE develops distinct, family-specific activation patterns, providing interpretable evidence of dynamic parameterization across protein classes. Zero-shot tests on DUDE-Z and LIT-PCBA further show strong EF5% performance, making HydrAffinity a practical, scalable solution acting as an effective early-stage pre-filter. Graphic abstract
Despite challenges related to data sparsity and conformational variability, ViTs show strong performance and high robustness in structure-based affinity prediction tasks, underscore their effectiveness in learning spatial patterns and suggest broader applicability to related tasks, such as protein-protein or protein-nu...
Jakub Poziemski, Paweł Siedlecki· Scientific Reports· 0 citations
The proposed MSIGR-PLA is an integrative framework that integrates local multi-scale interaction features with global protein-ligand representations to improve the accuracy of PLA prediction and consistently outperforms existing methods on four benchmark datasets.
Hangchen Zhang, Haoran Chen, Chang Liu et al.· IEEE journal of biomedical a...· 0 citations
This work designs a biological prior-guided feature fusion framework that integrates pseudo-structural epitope knowledge and CDR-specific attention mechanisms via a mixture-of-experts architecture to effectively capture complex binding landscapes in antibody screening and drug residence time analysis.
G. Luo, Junkai Wang, Sizhe Zhang et al.· Bioinformatics· 0 citations
A category-stratified, statistically powered benchmark comparing pose prediction from receptor conformational ensembles against AlphaFold2, used as a matched static-structure baseline, across 29 protein–ligand systems spanning cryptic-pocket, induced-fit, water-mediated, and autoimmune-indication target classes is pres...
Ryan Varghese, Pooja Tiwary, Krishil Oswal· bioRxiv· 0 citations
Abstract Motivation To enable real-world protein-ligand affinity prediction, not only out-of-distribution generalization but also robustness to variable structural availability and quality should be considered in model design. Results We present AlignNet, a hierarchical representation alignment framework that mitigates...
Xiaowen Hu, Hong-Yi Huang, Hao Sun et al.· Bioinform.· 0 citations
Protein-ligand binding affinity (PLA) prediction aims to guide rational drug design by estimating the strength of interaction. The effectiveness of the representation learning of protein and ligand is key to successful PLA prediction. To this end, attention mechanism, as a powerful architectural paradigm, has been intr...
Changming Yao, Shunfanyi Li, Shanghui Deng et al.· IEEE transactions on computa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.